New drug aims to stop Post-Surgery breathing danger
Prevention
Not yet recruiting
This Phase 2 trial tests whether the drug ENA-001 can prevent respiratory depression (dangerously slow or shallow breathing) after major surgery under general anesthesia. About 200 adults having elective surgery will receive either ENA-001 or a placebo as an IV drip. The study is…
Phase: PHASE2 • Sponsor: Enalare Therapeutics Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC